Combined Consideration of Sex, Genotype, and Total Liver Volume Progression Determines the Risk of Hospitalization in an International Multicenter Cohort of Autosomal Dominant Polycystic Liver Disease
Dana Sierks, Jan Halbritter(Humboldt-Universität zu Berlin), Tabinda Jawaid(Mayo Clinic), J Degenhardt(University Hospital Cologne), Jonathan de Fallois(University of Cologne), Whitney Besse(Yale University), John A. Sayer(Newcastle University), Marie‐Pierre Audrézet(Inserm), Joost P.H. Drenth(Amsterdam Neuroscience), Ria Schönauer(Charité - Universitätsmedizin Berlin), Frederik Nevens(KU Leuven), Thomas Berg(Leipzig University of Applied Sciences), Terry Watnick(University of Maryland, Baltimore), Bernhard Schlevogt(University Hospital Münster), Émilie Cornec-Le Gall(Inserm), Peter C. Harris(Mayo Clinic), Léa Caroff(Université de Bretagne Occidentale), Melissa M. Boerrigter(Radboud University Nijmegen)
Cited by 0
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
|Gastroenterology|2016|1k
ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis
|New England Journal of Medicine|2014|877
United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU)
|United European Gastroenterology Journal|2017|698
A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome
|Journal of the American Society of Nephrology|2014|660